Home › Trials › NCT06656884

Assessment of workflow practices for atrial fibrillation treatment using FARAPULSE technology

FARAPULSE Workflow Assessment Registry

Observational Boston Scientific Corporation · NCT06656884

This study is testing how to improve the treatment process for atrial fibrillation using a new technology called FARAPULSE to see what works best for patients.

Quick facts

Study typeObservational
Enrollment500 (estimated)
Ages18 Years and up
SexAll
SponsorBoston Scientific Corporation Industry-sponsored
Locations32 sites (Linz and 31 other locations)
Trial IDNCT06656884 on ClinicalTrials.gov

What this trial studies

This observational study aims to evaluate best practices in the patient pathway for atrial fibrillation treatment using the FARAPULSE™ Pulsed Field Ablation System. It will analyze various workflow data, including pre-procedural imaging, anesthesia techniques, and procedural management, to identify effective strategies associated with patient demographics and outcomes. The goal is to optimize procedural workflows based on collected data to enhance safety and effectiveness in treating atrial fibrillation.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older who are scheduled for treatment with the FARAPULSE™ system and can provide informed consent.

Not a fit: Patients currently enrolled in other investigational studies or those who have previously undergone left atrium ablation may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment outcomes and safety for patients undergoing ablation for atrial fibrillation.

How similar studies have performed: While this study focuses on a specific technology and workflow assessment, similar studies in procedural optimization have shown promise in improving patient outcomes.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Subjects are prospectively planned and intended to be treated with the FARAPULSE™ Pulsed Field Ablation system for cardiac tissue ablation, per physician's medical judgement, and as per hospitals' standard of care
* Subjects who are willing and capable of providing informed consent
* Subjects who are willing and capable of participating to this Registry at an approved clinical investigational center
* Subjects whose age is 18 years or above, or who are of legal age to give informed consent specific to state and national law

Exclusion Criteria:

* Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study. Exceptions are when the subject is participating in a mandatory governmental registry, or a purely observational registry, that do not interfere with the current study
* Prior Left Atrium Ablation

Where this trial is running

Linz and 31 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Atrial FibrillationCatheter AblationPulsed Field AblationFARAPULSEWorkflow Assessment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.